<DOC>
	<DOCNO>NCT00128856</DOCNO>
	<brief_summary>This multicenter , open-label , phase II trial ass efficacy GAT neoadjuvant regimen patient stage III breast cancer , confirm true-cut open biopsy .</brief_summary>
	<brief_title>Gemcitabine , Doxorubicin Paclitaxel ( GAT ) Neoadjuvant Treatment Breast Cancer Patients</brief_title>
	<detailed_description>2 treatment cycle chemotherapy ( one cycle = 2 week ) must administer patient breast surgery . The required number patient calculate follow Simon â€™ method . 43 patient enrol two phase : first , 29 patient must enrol , least 2 pathological complete response obtain . Patients recruitment continue 43 patient enrol . Assumptions 95 % probability obtain rate pathological complete response least 10 % .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Liposomal doxorubicin</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<criteria>Stage III breast cancer disease , histological confirmation truecut openbiopsy . Ages 18 75 year old . Patients older 70 must adequate quality life eligible . Patients receive previous treatment chemotherapy , hormone therapy , radiotherapy immune therapy . Performance status 0,1 , 2 ( ECOG ) . At least 6 month life expectancy . Neutrophils &gt; 1500 ; platelet &gt; 100000 ; haemoglobin &gt; 10 mg/dL . Adequate renal hepatic function , serum creatinine &lt; 1.2 mg/dl total bilirubin &lt; 2 mg/dl . Adequate contraceptive method study 3 month . Adequate cardiac function assess physical exam , electrocardiogram ( EKG ) leave ventricular ejection fraction ( LVEF ) &gt; 55 % . Inflammatory carcinoma stage I , II IV breast cancer disease . Males . Active infection . Other neoplasms except basal skin carcinoma cervical situ carcinoma adequately treat . Other previous neoplasm allow diagnose treat 5 year study registration . Concomitant serious disease provoke organ failure ( heart , renal , hepatic , respiratory ) . Preexisting motor sensorial neuropathy &gt; grade 1 . Inability treatment compliance . History hypersensitivity compound cremophor , cyclosporine vitamin K. History arrhythmias congestive heart failure , even control ; active cardiac block second third grade . History myocardial infarction previous 6 month . Hypertension ( HT ) control . Pregnant lactating woman .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2005</verification_date>
	<keyword>Neoadjuvant chemotherapy .</keyword>
	<keyword>Stage III disease .</keyword>
</DOC>